Dynamics of apelin receptor/G protein coupling in living cells

Experimental Cell Research

Volumn 328, Issue 2, 2014, Pages 401-409

  Bai, Bo ^a   Jiang, Yunlu ^a   Cai, Xin ^a   Chen, Jing ^a,b  

^a JINING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Apelin receptor; G protein subunit; G protein coupled receptor; Resonance energy transfer

Indexed keywords

APELIN; APELIN 13; APELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; UNCLASSIFIED DRUG; APELIN-13 PEPTIDE; APLNR PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; PROTEIN SUBUNIT; SIGNAL PEPTIDE;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONTROLLED STUDY; DNA SEQUENCE; FORSTER RESONANCE ENERGY TRANSFER; HEK293 CELL LINE; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; SIGNAL TRANSDUCTION; CELL LINE; METABOLISM;

CELL LINE; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN SUBUNITS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84908179214     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.08.035     Document Type: Article

References (41)

1. Lagerstrom M.C., Schioth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 2008, 7:339-357.
2. Regard J.B., Sato I.T., Coughlin S.R. Anatomical profiling of G protein-coupled receptor expression. Cell 2008, 135:561-571.
3. Loot A.E., Fleming I. A novel APJ signaling cascade that regulates cardiovascular development. Circ. Res. 2013, 113:4-6.
4. Dai L., Smith P.M., Kuksis M., Ferguson A.V. Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function. J. Physiol. 2013, 591:3421-3432.
5. Hosoya M., Kawamata Y., Fukusumi S., Fujii R., Habata Y., Hinuma S., Kitada C., Honda S., Kurokawa T., Onda H., Nishimura O., Fujino M. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J. Biol. Chem. 2000, 275:21061-21067.
6. Kidoya H., Takakura N. Biology of the apelin-APJ axis in vascular formation. J. Biochem. 2012, 152:125-131.
7. Scimia M.C., Hurtado C., Ray S., Metzler S., Wei K., Wang J., Woods C.E., Purcell N.H., Catalucci D., Akasaka T., Bueno O.F., Vlasuk G.P., Kaliman P., Bodmer R., Smith L.H., Ashley E., Mercola M., Brown J.H., Ruiz-Lozano P. APJ acts as a dual receptor in cardiac hypertrophy. Nature 2012, 488:394-398.
8. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991, 349:117-127.
9. Cabrera-Vera T.M., Vanhauwe J., Thomas T.O., Medkova M., Preininger A., Mazzoni M.R., Hamm H.E. Insights into G protein structure, function, and regulation. Endocr. Rev. 2003, 24:765-781.
10. Bünemann M., Frank M., Lohse M.J. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc. Natl. Acad. Sci. USA 2003, 100:16077-16082.
11. Masri B., Morin N., Pedebernade L., Knibiehler B., Audigier Y. The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. J. Biol. Chem. 2006, 281:18317-18326.
12. Szokodi I., Tavi P., Foldes G., Voutilainen-Myllyla S., Ilves M., Tokola H., Pikkarainen S., Piuhola J., Rysa J., Toth M., Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ. Res. 2002, 91:434-440.
13. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.-X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 1998, 251:471-476.
14. Becker J.A., Wallace A., Garzon A., Ingallinella P., Bianchi E., Cortese R., Simonin F., Kieffer B.L., Pessi A. Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library. J. Biol. Chem. 1999, 274:27513-27522.
15. Ruiz-Velasco V., Ikeda S.R. Functional expression and FRET analysis of green fluorescent proteins fused to G-protein subunits in rat sympathetic neurons. J. Physiol. 2001, 537:679-692.
16. Hein P., Frank M., Hoffmann C., Lohse M.J., Bunemann M. Dynamics of receptor/G protein coupling in living cells. EMBO J. 2005, 24:4106-4114.
17. Lohse M.J., Nuber S., Hoffmann C. Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling. Pharmacol. Rev. 2012, 64:299-336.
18. Xia Z., Liu Y. Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys. J. 2001, 81:2395-2402.
19. Kocan M., Dalrymple M.B., Seeber R.M., Feldman B.J., Pfleger K.D. Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions between GPCRs and beta-arrestins. Front. Endocrinol. 2010, 1:12.
20. Li Y., Chen J., Bai B., Du H., Liu Y., Liu H. Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction. Cell. Signal. 2012, 24:991-1001.
21. Sauliere A., Bellot M., Paris H., Denis C., Finana F., Hansen J.T., Altie M.F., Seguelas M.H., Pathak A., Hansen J.L., Senard J.M., Gales C. Deciphering biased-agonism complexity reveals a new active AT1 receptor entity. Nat. Chem. Biol. 2012, 8:622-630.
22. Pfleger K.D., Seeber R.M., Eidne K.A. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat. Protoc. 2006, 1:337-345.
23. Wettschureck N., Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 2005, 85:1159-1204.
24. Frank M., Thümer L., Lohse M.J., Bünemann M. G protein activation without subunit dissociation depends on a Gαi-specific region. J. Biol. Chem. 2005, 280:24584-24590.
25. Vilardaga J.P., Bunemann M., Feinstein T.N., Lambert N., Nikolaev V.O., Engelhardt S., Lohse M.J., Hoffmann C. GPCR and G proteins: drug efficacy and activation in live cells. Mol. Endocrinol. 2009, 23:590-599.
26. Robishaw J.D., Berlot C.H. Translating G protein subunit diversity into functional specificity. Curr. Opin. Cell Biol. 2004, 16:206-209.
27. Wilson S., Wilkinson G., Milligan G. The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J. Biol. Chem. 2005, 280:28663-28674.
28. Ayoub M.A., Al-Senaidy A., Pin J.P. Receptor-G protein interaction studied by bioluminescence resonance energy transfer: lessons from protease-activated receptor 1. Front. Endocrinol. 2012, 3:82.
29. Kang Y., Kim J., Anderson J.P., Wu J., Gleim S.R., Kundu R.K., McLean D.L., Kim J.D., Park H., Jin S.W., Hwa J., Quertermous T., Chun H.J. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circ. Res. 2013, 113:22-31.
30. Bai B., Tang J., Liu H., Chen J., Li Y., Song W. Apelin-13 induces ERK1/2 but not p38 MAPK activation through coupling of the human apelin receptor to the Gi2 pathway. Acta Biochim. Biophys. Sin. 2008, 40:311-318.
31. O'Carroll A.M., Lolait S.J., Harris L.E., Pope G.R. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis. J. Endocrinol. 2013, 219:R13-R35.
32. Gurevich V.V., Gurevich E.V. How and why do GPCRs dimerize?. Trends Pharmacol. Sci. 2008, 29:234-240.
33. Mandrika I., Petrovska R., Klovins J. Evidence for constitutive dimerization of niacin receptor subtypes. Biochem. Biophys. Res. Commun. 2010, 395:281-287.
34. Herrick-Davis K., Grinde E., Cowan A., Mazurkiewicz J.E. Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle. Mol. Pharmacol. 2013, 84(4):630-642.
35. Rozenfeld R., Devi L.A. Receptor heteromerization and drug discovery. Trends Pharmacol. Sci. 2010, 31:124-130.
36. Ward R.J., Xu T.R., Milligan G. GPCR oligomerization and receptor trafficking. Methods Enzymol. 2013, 521:69-90.
37. Suzuki T., Namba K., Mizuno N., Nakata H. Hetero-oligomerization and specificity changes of G protein-coupled purinergic receptors: novel insight into diversification of signal transduction. Methods Enzymol. 2013, 521:239-257.
38. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., Deng A., Eichhorn J., Mahajan R., Agrawal R., Greve J., Robbins R., Patterson A.J., Bernstein D., Quertermous T. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc. Res. 2005, 65:73-82.
39. Jia Y.X., Pan C.S., Zhang J., Geng B., Zhao J., Gerns H., Yang J., Chang J.K., Tang C.S., Qi Y.F. Apelin protects myocardial injury induced by isoproterenol in rats. Regul. Pept. 2006, 133:147-154.
40. Chun H.J., Ali Z.A., Kojima Y., Kundu R.K., Sheikh A.Y., Agrawal R., Zheng L., Leeper N.J., Pearl N.E., Patterson A.J., Anderson J.P., Tsao P.S., Lenardo M.J., Ashley E.A., Quertermous T. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J. Clin. Investig. 2008, 118:3343-3354.
41. Siddiquee K., Hampton J., Khan S., Zadory D., Gleaves L., Vaughan D.E., Smith L.H. Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. J. Hypertens. 2011, 29:724-731.